SeekIn Demonstrates the Power of Treatment Response Monitoring Test at the Association for Molecular Pathology (AMP) 2022 Annual Meeting & Expo

SeekInClarity is a CE-IVD Mark, cost-effective, blood-based pan-cancer/pan-indication treatment response monitoring test that does not require cancer tissue analysis.

SeekInClarity test could identify a subgroup of patients as responders, who have better survival regardless of disease subtypes and stages, after the first or second cycles of treatment.

https://www.biospace.com/article/releases/seekin-demonstrates-the-power-of-treatment-response-monitoring-test-at-the-association-for-molecular-pathology-amp-2022-annual-meeting-and-expo/